Malignant Thoracic Neoplasm — Trials

Malignant Thoracic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,496 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,773
Recruiting: 1,496
Ph III recruiting: 183
Growth YoY: +7.3%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,526)

clinicaltrialsPublishedShowing 301–350 of 1,942 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07079475	Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)	recruiting	Phase 1 / Phase 2	220	Dizal PharmaceuticalsINDUSTRY	1	Aug 31, 2026	clinicaltrials
NCT07322341	SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer	recruiting	Phase 2	32	University of WashingtonOTHER	1	Aug 31, 2026	clinicaltrials